Associate Professor North Carolina Agricultural and Technical State University
This study examines how stigma, provider communication, and the CDC’s opioid prescribing regulations impact sickle cell patients’ healthcare experiences. Findings highlight barriers in emergency care, challenges with pain management, and the need for culturally competent care to improve patient-provider communication and ensure equitable treatment.
Learning Objectives:
At the end of this session, attendees should be able to:
Describe how stigma and racial bias impact sickle cell patients’ access to effective pain management and treatment, particularly within emergency department settings.
Analyze the effects of the CDC’s opioid prescribing regulations on sickle cell patients’ healthcare experiences and their ability to receive adequate pain management.
Evaluate strategies for improving patient-provider communication and reducing healthcare disparities in sickle cell disease treatment through culturally competent care and bias-free medical training.
